Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 1.1. It has been cited 22 times, with 20 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0.625
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 20 citers.
Merck
Grant: Merck Investigator Studies Program
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 5P50CA254865-02
Melanoma and Skin Cancer Program SPORE
National Institutes of Health
Grant: 1R01DE031729-01A1
Immune Exclusion in Cancer Immunotherapy
National Institutes of Health
Grant: 5UM1CA186690-09
NCI ETCTN Pittsburgh Cancer Consortium (PCC)
FWCI
3.55
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals